Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
0.00 (0.00%)
USD |
NASDAQ |
Mar 11, 16:00
Harpoon Therapeutics Free Cash Flow: -69.50M for Sept. 30, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2023 | -69.50M |
| June 30, 2023 | -77.10M |
| March 31, 2023 | -83.58M |
| December 31, 2022 | -89.53M |
| September 30, 2022 | -88.00M |
| June 30, 2022 | -84.46M |
| March 31, 2022 | -129.37M |
| December 31, 2021 | -122.25M |
| September 30, 2021 | -120.59M |
| June 30, 2021 | -113.87M |
| Date | Value |
|---|---|
| March 31, 2021 | -9.899M |
| December 31, 2020 | -9.299M |
| September 30, 2020 | 39.28M |
| June 30, 2020 | 40.24M |
| March 31, 2020 | -11.43M |
| December 31, 2019 | -6.407M |
| September 30, 2019 | -46.36M |
| June 30, 2019 | -40.66M |
| March 31, 2019 | -33.05M |
| December 31, 2018 | -27.79M |
Free Cash Flow Range, Past 5 Years
-129.37M
Minimum
Mar 2022
40.24M
Maximum
Jun 2020
-56.82M
Average
-73.30M
Median
Free Cash Flow Benchmarks
| Merck & Co Inc | 11.04B |
| Axonics Inc | -16.29M |
| Johnson & Johnson | 18.23B |
| Boston Scientific Corp | 1.553B |
| Ambrx Biopharma Inc (DELISTED) | -58.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -16.53M |
| Cash from Investing (Quarterly) | -1.029M |
| Cash from Financing (Quarterly) | 2.032M |
| Free Cash Flow Per Share (Quarterly) | -4.210 |
| Free Cash Flow to Equity (Quarterly) | -16.62M |
| Free Cash Flow Yield | -81.57% |